EP 4301786 A1 20240110 - ANTI-VSIG4 ANTIBODY OR ANTIGEN BINDING FRAGMENT AND USES THEREOF
Title (en)
ANTI-VSIG4 ANTIBODY OR ANTIGEN BINDING FRAGMENT AND USES THEREOF
Title (de)
ANTI-VSIG4-ANTIKÖRPER ODER ANTIGENBINDENDES FRAGMENT UND VERWENDUNGEN DAVON
Title (fr)
ANTICORPS ANTI-VSIG4 OU FRAGMENT DE LIAISON À L'ANTIGÈNE ET SES UTILISATIONS
Publication
Application
Priority
- EP 21305253 A 20210303
- EP 2022055456 W 20220303
Abstract (en)
[origin: WO2022184853A1] New anti-VSIG4 (V-set Ig domain-containing 4) antibodies or an antigen-binding fragments are disclosed. Uses of these antibodies, including methods of treatment, are also provided.
IPC 8 full level
C07K 16/30 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP KR US)
A61K 39/3955 (2013.01 - US); A61K 47/6849 (2017.07 - US); A61P 35/00 (2017.12 - KR US); C07K 16/2803 (2013.01 - EP); C07K 16/2827 (2013.01 - KR US); C07K 16/30 (2013.01 - KR); G01N 33/532 (2013.01 - US); G01N 33/57484 (2013.01 - KR); G01N 33/57492 (2013.01 - US); A61K 2039/505 (2013.01 - EP KR); C07K 2317/21 (2013.01 - EP KR US); C07K 2317/24 (2013.01 - US); C07K 2317/34 (2013.01 - EP); C07K 2317/622 (2013.01 - EP KR US); C07K 2317/76 (2013.01 - EP KR); C07K 2317/77 (2013.01 - EP KR); C07K 2317/92 (2013.01 - EP KR); G01N 2333/70532 (2013.01 - US)
Citation (search report)
See references of WO 2022184853A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022184853 A1 20220909; EP 4301786 A1 20240110; KR 20230156727 A 20231114; TW 202302645 A 20230116; US 2024158503 A1 20240516
DOCDB simple family (application)
EP 2022055456 W 20220303; EP 22711002 A 20220303; KR 20237032971 A 20220303; TW 111107826 A 20220303; US 202218280068 A 20220303